Dow Today: E.I. Du Pont De Nemours & Company (DD) Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 81 points (+0.5%) at 15,453 as of Tuesday, Feb 4, 2014, 11:35 a.m. ET. During this time, 213.8 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 369.3 million. The NYSE advances/declines ratio sits at 2,024 issues advancing vs. 894 declining with 170 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be E.I. du Pont de Nemours & Company (NYSE: DD), which is sporting a $1.87 gain (+3.1%) bringing the stock to $61.86. This single gain is lifting the Dow Jones Industrial Average by 14.15 points or roughly accounting for 17.5% of the Dow's overall gain. Volume for E.I. du Pont de Nemours & Company currently sits at six million shares traded vs. an average daily trading volume of 4.2 million shares.

E.I. du Pont de Nemours & Company has a market cap of $56.5 billion and is part of the basic materials sector and chemicals industry. Shares are down 7.7% year to date as of Monday's close. The stock's dividend yield sits at 3%.

E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. Its Agriculture segment provides corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, and rice seed products under the Pioneer brand; and herbicides, fungicides, and insecticides. The company has a P/E ratio of 20.1, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates E.I. du Pont de Nemours & Company as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

DowDupont Closes Higher in First Day of Trading, Company Still Faces Challenges

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

FMC Stock's Impressive Rally Has Another 20% to Gain: Jim Cramer

Jim Cramer on Why FMC Was Upgraded by Bank of America